Imaging TMS: antidepressant mechanisms and treatment optimization

Area of Science:

• Neuroscience
• Psychiatry
• Medical Imaging

Background:

• The antidepressant efficacy of Transcranial Magnetic Stimulation (TMS) is well-established.
• There is increasing interest in understanding the mechanisms underlying TMS's effectiveness.
• Dysfunctional brain networks and neurotransmitter systems are implicated in depression.

Purpose of the Study:

• To review the effects of TMS on brain networks and neurotransmitter systems relevant to depression.
• To suggest candidate neuroimaging biomarkers for predicting response to TMS.
• To discuss how personalized treatment strategies can optimize TMS efficacy.

Main Methods:

• Review of existing literature on TMS, neuroimaging, and depression.
• Identification and discussion of potential neuroimaging biomarkers.
• Analysis of TMS effects on functional connectivity and neurotransmitter systems.

Main Results:

• TMS engages and can normalize dysfunctional brain networks in depression.
• Neuroimaging biomarkers may predict individual response to TMS.
• Understanding network engagement aids in treatment personalization.

Conclusions:

• TMS offers a viable antidepressant treatment by modulating brain networks.
• Neuroimaging biomarkers hold promise for predicting TMS treatment outcomes.
• Personalized approaches to TMS therapy can enhance treatment efficacy for depression.